Unknown

Dataset Information

0

Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin.


ABSTRACT: Endothelial lipase (EL) plays an important role in the regulation of lipid metabolism by reducing the high density lipoprotein cholesterol (HDL-C) levels and inducing the macrophages to take up native low density lipoprotein cholesterol (LDL-C). Our purpose was to investigate the impact of EL genetic polymorphisms on the lipid-lowering effects of rosuvastatin in Chinese coronary artery disease (CAD) patients.One hundred twenty-one unrelated CAD patients, who underwent the treatment with rosuvastatin (10mg/day) for four to eight weeks, were enrolled in this study. Before and after treatment, serum lipids levels were measured. Genotypes of EL 2037T/C and 2237 G/A polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.Patients with EL 2037C allele (CC?+?CT) had significantly lower LDL-C levels than those with TT genotype (CC?+?CT: 2.60?±?0.74 mmol/l; TT: 2.90?±?0.87 mmol/l; P?=?0.047), before rosuvastatin treatment. No significant differences between baseline lipid levels and the EL 2237G/A genotypes were observed. After treatment with rosuvastatin, total cholesterol (TC), high triglyceride (TG) and LDL-C levels decreased from baseline, on average, by 23.09 % (4.59?±?0.96 mmol/l to 3.47?±?0.83 mmol/l), 6.36 % (2.01?±?1.18 mmol/l to 1.68?±?1.16 mmol/l), 32.48 % (2.77?±?0.83 mmol/l to 1.79?±?0.62 mmol/l), respectively (all P?

SUBMITTER: Cai G 

PROVIDER: S-EPMC5012091 | biostudies-other | 2016 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin.

Cai Gaojun G   Zhang Bifeng B   Shi Ganwei G   Weng Weijin W   Yang Liping L   Xue Sheliang S  

Lipids in health and disease 20160906 1


<h4>Background</h4>Endothelial lipase (EL) plays an important role in the regulation of lipid metabolism by reducing the high density lipoprotein cholesterol (HDL-C) levels and inducing the macrophages to take up native low density lipoprotein cholesterol (LDL-C). Our purpose was to investigate the impact of EL genetic polymorphisms on the lipid-lowering effects of rosuvastatin in Chinese coronary artery disease (CAD) patients.<h4>Methods</h4>One hundred twenty-one unrelated CAD patients, who un  ...[more]

Similar Datasets

| S-EPMC3917734 | biostudies-literature
| S-EPMC5017691 | biostudies-literature
| S-EPMC6971494 | biostudies-literature
| S-EPMC10298211 | biostudies-literature
| S-EPMC5874287 | biostudies-literature
2022-08-11 | PXD013643 | Pride
| S-EPMC7890294 | biostudies-literature
| S-EPMC7494996 | biostudies-literature
| S-EPMC4486941 | biostudies-literature
| S-EPMC6031176 | biostudies-literature